Evidence map›Paper›PMID 35010301›Full record

ArticleInternational journal of environmental research and public health2021

Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.

Jasmina Grujić, Nevenka Bujandrić, Zorana Budakov-Obradović, Vladimir Dolinaj, Damir Bogdan, Nebojša Savić, Alejandro Cabezas-Cruz, Dragana Mijatović, Verica Simin, Nikola Anđelić and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jasmina GrujićBlood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.ORCID 0000-0003-3092-4768
Nevenka BujandrićBlood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.ORCID 0000-0001-7331-5562
Zorana Budakov-ObradovićBlood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.
Vladimir DolinajFaculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
Damir BogdanSocial Sciences and Computing, University of Belgrade, 11000 Belgrade, Serbia.
Nebojša SavićTransfusion Medicine Department, Clinic for Vascular and Endovascular Surgery, Clinical Centre of Serbia, 11000 Belgrade, Serbia.
Alejandro Cabezas-CruzAnses, INRAE, Ecole Nationale Vétérinaire d'Alfort, UMR BIPAR, Laboratoire de Santé Animale, F-94700 Maisons-Alfort, France.ORCID 0000-0002-8660-730X
Dragana MijatovićDepartment of Prevention of Rabies and Other Infectious Diseases, Pasteur Institute Novi Sad, 21000 Novi Sad, Serbia.
Verica SiminDepartment of Microbiology, Pasteur Institute Novi Sad, 21000 Novi Sad, Serbia.
Nikola AnđelićFaculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
Pavle BanovićDepartment of Prevention of Rabies and Other Infectious Diseases, Pasteur Institute Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0001-7902-6606
University of Novi Sad · RSÉcole Nationale Vétérinaire d'Alfort · FRUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Passive immunotherapy with convalescent COVID-19 plasma (CCP) is used as a therapeutic procedure in many countries, including Serbia. In this study, we analyzed the association between demographic factors, COVID-19 severity and the reactivity of anti-SARS-CoV-2 antibodies (Abs) in Serbian CCP donors. Individuals (

Indexed as

COVID-19AgedAntibodies, ViralBlood DonorsCOVID-19 SerotherapyDemographyHumansImmunization, PassiveMaleSARS-CoV-2Antibodies, Viralconvalescent plasmaCOVID-19donorsSARS-CoV-2Serbiatherapy

Identifiers

PMID35010301
PMCPMC8751168
OpenAlexW4200259197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.